<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epigallocatechin <z:chebi fb="0" ids="16918">gallate</z:chebi> (<z:chebi fb="0" ids="4806">EGCG</z:chebi>), a major constituent of green tea, is a potent free radical scavenger </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to verify whether <z:chebi fb="0" ids="4806">EGCG</z:chebi> reduces focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced brain injury in a rat model </plain></SENT>
<SENT sid="2" pm="."><plain>Male Sprague-Dawley rats were anesthetized with chloral <z:chebi fb="1" ids="35505">hydrate</z:chebi> (400 mg/kg, i.p.) and subjected to a middle cerebral artery 2 h occlusion and then a 24-h reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="4806">EGCG</z:chebi> (25 mg and 50 mg/kg, i.p.) or vehicle was administered immediately after reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty-four hours after reperfusion, infarction size, levels of <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers (malondialdehyde and oxidized/total <z:chebi fb="0" ids="16856">glutathione</z:chebi> ratio) in the brain and neurological deficits were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>The dose of 50 mg/kg of <z:chebi fb="0" ids="4806">EGCG</z:chebi> significantly reduced the infarction volume (9.9+/-3.2%) as compared to those (45.6+/-5.3%, 34.5+/-7.8%) of the control group and the <z:chebi fb="0" ids="4806">EGCG</z:chebi> 25 mg/kg treated group (p&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>The dose of 50 mg/kg of <z:chebi fb="0" ids="4806">EGCG</z:chebi> significantly reduced the neurological deficit total score (5.2+/-1.7) as compared to those (9.5+/-1.2, 8.5+/-2.5) of the control group and the <z:chebi fb="0" ids="4806">EGCG</z:chebi> 25 mg/kg treated group (p&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>The dose of 50 mg/kg of <z:chebi fb="0" ids="4806">EGCG</z:chebi> significantly attenuated the level of malondialdehyde and the level of oxidized/total <z:chebi fb="0" ids="16856">glutathione</z:chebi> ratio (281+/-66 nmol/g and 0.48+/-0.03) as compared to the those (415+/-46 nmol/g and 0.64+/-0.05, 381+/-51 nmol/g and 0.61+/-0.06) of the control group and the <z:chebi fb="0" ids="4806">EGCG</z:chebi> 25 mg/kg treated group (p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>These results demonstrate the anti-oxidant effects of <z:chebi fb="0" ids="4806">EGCG</z:chebi> (50 mg/kg) in a rat model of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, which is a likely explanation for <z:chebi fb="0" ids="4806">EGCG</z:chebi>'s neuroprotective effects </plain></SENT>
</text></document>